XML 34 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings per Share (Tables)
 9 Months Ended
Nov. 03, 2018
Earnings Per Share [Abstract]  
Computation of basic and diluted earnings per share
The following tables show the computation of basic and diluted loss per common share for each period presented (in thousands, except per share amounts):
 
Three Months Ended
 
Nine Months Ended
 
November 3, 2018
 
October 28, 2017
 
November 3, 2018
 
October 28, 2017
Basic:
 
 
 
 
 
 
 
Net loss
$
(31,353
)
 
$
(17,722
)
 
$
(79,953
)
 
$
(42,967
)
Distributed earnings allocated to participating securities
(18
)
 
(66
)
 
(149
)
 
(268
)
Net loss allocated to common shares
(31,371
)
 
(17,788
)
 
(80,102
)

(43,235
)
 
 
 
 
 
 
 
 
Basic weighted average shares outstanding
28,261

 
27,602

 
28,059

 
27,468

Basic loss per share
$
(1.11
)
 
$
(0.64
)
 
$
(2.85
)
 
$
(1.57
)
 
 
 
 
 
 
 
 
 
Three Months Ended
 
Nine Months Ended
 
November 3, 2018
 
October 28, 2017
 
November 3, 2018
 
October 28, 2017
Diluted:
 

 
 

 
 
 
 
Net loss
$
(31,353
)
 
$
(17,722
)
 
$
(79,953
)
 
$
(42,967
)
Distributed earnings allocated to participating securities
(18
)
 
(66
)
 
(149
)
 
(268
)
Net loss allocated to common shares
(31,371
)
 
(17,788
)
 
(80,102
)

(43,235
)
 
 
 
 
 
 
 
 
Basic weighted average shares outstanding
28,261

 
27,602

 
28,059

 
27,468

Dilutive effect of stock awards
—

 
—

 
—

 
—

Diluted weighted average shares outstanding
28,261

 
27,602

 
28,059


27,468

Diluted loss per share
$
(1.11
)
 
$
(0.64
)
 
$
(2.85
)
 
$
(1.57
)
Number of anti-dilutive securities excluded from computation of diluted loss per share
The number of shares attributable to outstanding stock-based compensation awards that would have been considered dilutive securities, but were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive were as follows (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
November 3, 2018
 
October 28, 2017
 
November 3, 2018
 
October 28, 2017
Number of anti-dilutive shares due to net loss for the period
89

 
—

 
341

 
—

Number of anti-dilutive SARs due to exercise price greater than average market price of our common stock
—


113

 
19

 
129